A high VISTA expression is reported in hematopoietic lineage, particularly in tumor-infiltrating myeloid cells, such as myeloid DCs and MDSCs, and Tregs which support VISTA as an important target for immunotherapy. This evidence concerns the gene VSIR and neoplasm.